SEATTLE, March 25, 2026 /PRNewswire/ — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing…
Raanana, Israel, March 25, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company…
Convening Notice for Annual General Meeting of Shareholders MILLICOM INTERNATIONAL CELLULAR S.A.Registered Address:148-150, Boulevard de la PétrusseL-2330, Grand Duchy of…